American Journal of Roentgenology, Vol 167, 1579-1584, Copyright © 1996 by American Roentgen Ray Society

ARTICLES

Cranial MR imaging in Wilson's disease

AD King, JM Walshe, BE Kendall, RJ Chinn, MN Paley, ID Wilkinson, S Halligan and MA Hall-Craggs
Department of Radiology, Middlesex Hospital, London, England.

OBJECTIVE: The purpose of the study was to describe the range of abnormalities seen on cranial MR images of patients with Wilson's disease and correlate the findings with clinical severity, duration of disease, and duration of neurologic signs and symptoms before treatment. In those patients with serial studies, the changes on MR images were compared with the clinical response. SUBJECTS AND METHODS: Twenty-five patients with Wilson's disease underwent MR imaging of the brain using conventional spin-echo sequences (n = 25), phase maps (n = 8), and partially refocused interleaved multiple-echo sequences (n = 5). RESULTS: MR imaging findings were abnormal in 22 patients and normal in three patients. The basal ganglia were interpreted as abnormal in 19 (86%) of 22 patients, involving the putamen in 19 (86%), the thalami in 12 (54%), the caudate head in 10 (45%), and the globus pallidus in nine (41%). We found a predilection for involvement of the outer rim of the putamen and the ventral nuclear mass of the thalami. The claustrum was abnormal in three patients. The midbrain was abnormal in 17 (77%) of these 22 patients, affecting predominantly the tegmentum but also the substantia nigra, red nuclei, inferior tectum, and crura. The pons was abnormal in 18 (82%) of 22 patients, and the cerebellum was abnormal in 11 patients (50%), with involvement of the superior and middle cerebellar peduncles. Atrophy was present in 18 (82%) of 22 patients, and cortical white matter changes were apparent in 13 (59%) of 22 patients. The scan of one untreated patient revealed shortening of the T1 relaxation time in the thalami, which was consistent with the paramagnetic effects of copper. Phase maps and partially refocused interleaved multiple-echo sequences performed in eight and five patients, respectively, and used to reveal a susceptibility change induced by iron or copper showed normal findings. We found a significant inverse relationship between severity, but not extent, of change in signal intensity and the length of untreated disease (p = .030) and the total duration of disease (p = .015). The study group was too small to show a correlation with clinical findings. Changes seen on MR images matched the clinical response to treatment in only two of the seven patients who underwent follow-up studies. CONCLUSION: MR imaging revealed abnormalities in the basal ganglia, cerebral white matter, midbrain, pons, and cerebellum. The paramagnetic effects of copper were detected only in untreated patients. Patients with a longer duration of disease had less severe changes in signal intensity. MR imaging was of limited value in follow-up.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				S Sinha, A B Taly, L K Prashanth, S Ravishankar, G R Arunodaya, and M K Vasudev Sequential MRI changes in Wilson's disease with de-coppering therapy: a study of 50 patients Br. J. Radiol., September 1, 2007; 80(957): 744 - 749. [Abstract] [Full Text] [PDF]

				D. Aikath, A. Gupta, I. Chattopadhyay, M. A. Hashmi, P. K. Gangopadhyay, S. K. Das, and K. Ray Subcortical white matter abnormalities related to drug resistance in Wilson disease. Neurology, September 12, 2006; 67(5): 878 - 880. [Abstract] [Full Text] [PDF]

				T.J. Kim, I.O. Kim, W.S. Kim, J.E. Cheon, S.G. Moon, J.W. Kwon, J.K. Seo, and K.M. Yeon MR Imaging of the Brain in Wilson Disease of Childhood: Findings Before and After Treatment with Clinical Correlation AJNR Am. J. Neuroradiol., June 1, 2006; 27(6): 1373 - 1378. [Abstract] [Full Text] [PDF]

				P. Favrole, H. Chabriat, J. P. Guichard, and F. Woimant Clinical correlates of cerebral water diffusion in Wilson disease Neurology, February 14, 2006; 66(3): 384 - 389. [Abstract] [Full Text] [PDF]

				U. Walter, K. Krolikowski, B. Tarnacka, R. Benecke, A. Czlonkowska, and D. Dressler Sonographic detection of basal ganglia lesions in asymptomatic and symptomatic Wilson disease Neurology, May 24, 2005; 64(10): 1726 - 1732. [Abstract] [Full Text] [PDF]

				L. T. Lucato, M. C. G. Otaduy, E. R. Barbosa, A. A. C. Machado, A. McKinney, L. A. Bacheschi, M. Scaff, G. G. Cerri, and C. C. Leite Proton MR Spectroscopy in Wilson Disease: Analysis of 36 Cases AJNR Am. J. Neuroradiol., May 1, 2005; 26(5): 1066 - 1071. [Abstract] [Full Text] [PDF]

				R. A. Page, C. A. Davie, D. MacManus, K. A. Miszkiel, J. M. Walshe, D. H. Miller, A. J. Lees, and A. H.V. Schapira Clinical correlation of brain MRI and MRS abnormalities in patients with Wilson disease Neurology, August 24, 2004; 63(4): 638 - 643. [Abstract] [Full Text] [PDF]

				R.N. Sener Diffusion MR Imaging Changes Associated with Wilson Disease AJNR Am. J. Neuroradiol., May 1, 2003; 24(5): 965 - 967. [Abstract] [Full Text] [PDF]

				H. Barthel, W. Hermann, R. Kluge, S. Hesse, D. R. Collingridge, A. Wagner, and O. Sabri Concordant Pre- and Postsynaptic Deficits of Dopaminergic Neurotransmission in Neurologic Wilson Disease AJNR Am. J. Neuroradiol., February 1, 2003; 24(2): 234 - 238. [Abstract] [Full Text] [PDF]

				G V McDonnell and T F G Esmonde A homesick student Postgrad. Med. J., June 1, 1999; 75(884): 375 - 378. [Full Text]

				A R. o. t. ANPA Committee on Research, E. C. Lauterbach, J. L. Cummings, J. Duffy, C. E. Coffey, D. Kaufer, M. Lovell, P. Malloy, A. Reeve, D. R. Royall, et al. Neuropsychiatric Correlates and Treatment of Lenticulostriatal Diseases: A Review of the Literature and Overview of Research Opportunities in Huntington's, Wilson's, and Fahr's Diseases J Neuropsychiatry Clin Neurosci, August 1, 1998; 10(3): 249 - 266. [Abstract] [Full Text]